Five Prime Therapeutics to Participate in the 38th Annual J.P. Morgan Healthcare Conference
December 30 2019 - 1:05PM
Business Wire
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage
biotechnology company focused on developing immune modulators and
precision therapies for solid tumor cancers, will participate in
the 38th Annual J.P. Morgan Healthcare Conference on Thursday,
January 16, 2020. William Ringo, who is Five Prime’s Chairman and
interim Chief Executive Officer, will represent the company and
respond to questions from investors. He is scheduled to present at
7:30 a.m. PT (10:30 a.m. ET).
Investors and other interested parties will be able to access a
live audio webcast of the presentation by visiting
http://investor.fiveprime.com/events-presentations. A replay of the
presentation will also be available on the Five Prime website for
30 days after the conference.
About Five Prime
Five Prime Therapeutics, Inc. develops innovative protein
therapeutics to improve the lives of patients with cancer. The
company focuses on developing immune modulators and precision
therapies for solid tumor cancers paired with companion diagnostics
to identify patients who are most likely to benefit from treatment
with Five Prime’s product candidates. The company’s product
candidates have innovative mechanisms of action and address patient
populations in need of better therapies. Five Prime has entered
into strategic collaborations with leading global pharmaceutical
companies and has promising product candidates in clinical and
preclinical development. For more information, please visit
www.fiveprime.com.
Source: Five Prime Therapeutics, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191230005080/en/
Media and Investor Contact Martin Forrest VP, Investor
Relations & Corporate Communications Five Prime Therapeutics,
Inc. 415-365-5625 martin.forrest@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Sep 2023 to Sep 2024